About: SPC manufacturing waiver
Pharma industry raises the alarm about stockpiling of generic drugs
The industry of innovative medicines is concerned with a recent vote in the European Parliament on the stockpiling of generic drugs, saying that it causes uncertainty over innovation in the pharmaceutical field.Discussion heats up over stockpiling of generic drugs under patent protection
The Commission has announced its intention to add a manufacturing waiver to supplementary protection certificates (SPC), as part of its upgraded 2015 Single Market Strategy.The European Commission should shelve its patent law proposal
The European Commission is considering an initiative that would permanently hobble the continent's economy, writes Jan Fischer.Protecting the spark, avoiding the storm
Every new treatment, every transformational shift in the outlook for patients starts with the spark of an idea, writes Nathalie Moll.